Munshi Amit

Director at Inhibikase Therapeutics, Inc. · on record since Oct 23, 2024
Director at Arcutis Biotherapeutics, Inc. · on record since Jun 9, 2026
Director at SPESCOM SOFTWARE INC · on record since Jul 17, 2014
Chief Executive Officer at SPESCOM SOFTWARE INC · on record since Mar 2, 2015
President and CEO at ARENA PHARMACEUTICALS INC · on record since May 11, 2016
Director at ARENA PHARMACEUTICALS INC · on record since Feb 14, 2017
Director at Ruthigen, Inc. · on record since Jun 15, 2017
Director at Damora Therapeutics, Inc. · on record since Oct 28, 2020
Director at Social Capital Suvretta Holdings Corp. IV · on record since Jun 29, 2021
Director at Zura Bio Ltd · on record since Mar 21, 2023

Insider trading activity of Munshi Amit

Transactions on record: 131; since Jul 17, 2014

Open-market buys: 12; $1.5M

Open-market sells: 20; $29.2M

Companies traded: 7; last filing Jun 30, 2026

Figures computed from official regulatory filings — methodology.

Companies where Munshi Amit has traded

Inhibikase Therapeutics, Inc.7 tx · $500.1K · Jun 30, 2026
Zura Bio Ltd6 tx · $1M · Jun 22, 2026
Arcutis Biotherapeutics, Inc.3 tx · Dec 8, 2025
Damora Therapeutics, Inc.8 tx · $50K · Jun 20, 2025
ARENA PHARMACEUTICALS INC78 tx · $37.8M · Mar 11, 2022
Ruthigen, Inc.6 tx · Feb 1, 2021
SPESCOM SOFTWARE INC23 tx · $285.1K · Mar 1, 2016

Track record of Munshi Amit

Statistical track record

Free

Open-market buys: 12

Last buy: Oct 21, 2024

Win rates and median returns are available with a free account (5 insiders/month).

Create a free account

Transaction history of Munshi Amit

Co-insiders of Munshi Amit

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

Company	Filed	Type	Qty	Price	Value · USD	Src
Inhibikase Therapeutics, Inc.	Jun 30, 2026	AwardD	155,000	0.00 USD	—	SEC
Zura Bio Ltd	Jun 22, 2026	AwardD	51,000	0.00 USD	—	SEC
Inhibikase Therapeutics, Inc.	Feb 24, 2026	Other	-19,089	0.00 USD	$0	SEC
Arcutis Biotherapeutics, Inc.	Dec 8, 2025	Award	2,021	0.00 USD	$0	SEC
Arcutis Biotherapeutics, Inc.	Dec 8, 2025	AwardD	16,502	0.00 USD	$0	SEC
Arcutis Biotherapeutics, Inc.	Dec 8, 2025	AwardD	6,177	0.00 USD	$0	SEC
Inhibikase Therapeutics, Inc.	Jul 2, 2025	AwardD	108,176	0.00 USD	$0	SEC
Damora Therapeutics, Inc.	Jun 20, 2025	AwardD	720	0.00 USD	$0	SEC
Zura Bio Ltd	May 22, 2025	AwardD	51,000	0.00 USD	$0	SEC
Inhibikase Therapeutics, Inc.	Feb 19, 2025	AwardD	116,585	0.00 USD	$0	SEC
Inhibikase Therapeutics, Inc.	Feb 19, 2025	AwardD	56,600	0.00 USD	$0	SEC
Zura Bio Ltd	Dec 11, 2024	AwardD	117,000	0.00 USD	$0	SEC
Inhibikase Therapeutics, Inc.	Oct 23, 2024	AwardD	60,000	0.00 USD	$0	SEC
Inhibikase Therapeutics, Inc.	Oct 23, 2024	Buy	365,000	1.37 USD	$500.1K	SEC
Zura Bio Ltd	Sep 6, 2024	Award	159,744	3.13 USD	$500K	SEC
Damora Therapeutics, Inc.	Jun 21, 2024	AwardD	18,000	0.00 USD	$0	SEC
Damora Therapeutics, Inc.	Jun 15, 2023	AwardD	18,000	0.00 USD	$0	SEC
Zura Bio Ltd	Jun 5, 2023	Buy	117,647	4.25 USD	$500K	SEC
Zura Bio Ltd	Jun 2, 2023	AwardD	1,130,000	0.00 USD	$0	SEC
Damora Therapeutics, Inc.	Jun 15, 2022	AwardD	18,000	0.00 USD	$0	SEC
ARENA PHARMACEUTICALS INC	Mar 11, 2022	Other	-250	—	—	SEC
ARENA PHARMACEUTICALS INC	Mar 11, 2022	Other	-28,800	—	—	SEC
ARENA PHARMACEUTICALS INC	Mar 11, 2022	OtherD	-270,000	—	—	SEC
ARENA PHARMACEUTICALS INC	Mar 11, 2022	OtherD	-138,139	—	—	SEC
ARENA PHARMACEUTICALS INC	Mar 11, 2022	OtherD	-56,861	—	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
Inhibikase Therapeutics, Inc.	Jun 30, 2026	AwardD	155,000	0.00 USD	—	SEC
Zura Bio Ltd	Jun 22, 2026	AwardD	51,000	0.00 USD	—	SEC
Inhibikase Therapeutics, Inc.	Feb 24, 2026	Other	-19,089	0.00 USD	$0	SEC
Arcutis Biotherapeutics, Inc.	Dec 8, 2025	Award	2,021	0.00 USD	$0	SEC
Arcutis Biotherapeutics, Inc.	Dec 8, 2025	AwardD	16,502	0.00 USD	$0	SEC
Arcutis Biotherapeutics, Inc.	Dec 8, 2025	AwardD	6,177	0.00 USD	$0	SEC
Inhibikase Therapeutics, Inc.	Jul 2, 2025	AwardD	108,176	0.00 USD	$0	SEC
Damora Therapeutics, Inc.	Jun 20, 2025	AwardD	720	0.00 USD	$0	SEC
Zura Bio Ltd	May 22, 2025	AwardD	51,000	0.00 USD	$0	SEC
Inhibikase Therapeutics, Inc.	Feb 19, 2025	AwardD	116,585	0.00 USD	$0	SEC
Inhibikase Therapeutics, Inc.	Feb 19, 2025	AwardD	56,600	0.00 USD	$0	SEC
Zura Bio Ltd	Dec 11, 2024	AwardD	117,000	0.00 USD	$0	SEC
Inhibikase Therapeutics, Inc.	Oct 23, 2024	AwardD	60,000	0.00 USD	$0	SEC
Inhibikase Therapeutics, Inc.	Oct 23, 2024	Buy	365,000	1.37 USD	$500.1K	SEC
Zura Bio Ltd	Sep 6, 2024	Award	159,744	3.13 USD	$500K	SEC
Damora Therapeutics, Inc.	Jun 21, 2024	AwardD	18,000	0.00 USD	$0	SEC
Damora Therapeutics, Inc.	Jun 15, 2023	AwardD	18,000	0.00 USD	$0	SEC
Zura Bio Ltd	Jun 5, 2023	Buy	117,647	4.25 USD	$500K	SEC
Zura Bio Ltd	Jun 2, 2023	AwardD	1,130,000	0.00 USD	$0	SEC
Damora Therapeutics, Inc.	Jun 15, 2022	AwardD	18,000	0.00 USD	$0	SEC
ARENA PHARMACEUTICALS INC	Mar 11, 2022	Other	-250	—	—	SEC
ARENA PHARMACEUTICALS INC	Mar 11, 2022	Other	-28,800	—	—	SEC
ARENA PHARMACEUTICALS INC	Mar 11, 2022	OtherD	-270,000	—	—	SEC
ARENA PHARMACEUTICALS INC	Mar 11, 2022	OtherD	-138,139	—	—	SEC
ARENA PHARMACEUTICALS INC	Mar 11, 2022	OtherD	-56,861	—	—	SEC